Ensuring Medicine Supply Chain Resilience in Disasters: A Grounded Approach

By Staff Writer

August 18, 2023

Medicines and medical supplies are crucial in maintaining human health, particularly during disasters when their availability can be significantly impacted. This is especially true in developing countries, where the provision of these supplies is a critical priority. Disruptions in the medication supply chain can lead to serious consequences, from loss of revenue for companies to endangering lives. This article explores the causes, strategies, and consequences of such disruptions, using the Kermanshah, Iran earthquake in 2018 as a case study.

The study found that “waste of time and resources” was the most critical issue in the medication supply chain during disasters. Strategies to reduce this waste, such as efficient resource management and the use of an up-to-date information system, were identified as crucial in increasing supply chain resilience. Sociocultural factors, as well as the need for planning and designing an appropriate disaster management structure, were also highlighted as significant underlying factors affecting the prevention of resource waste.

The study emphasised the need for effective disaster management planning, and the importance of a comprehensive needs assessment based on the region’s characteristics, including its epidemiological needs, disease, and demographic characteristics. Paying attention to sociocultural factors and developing localised policies under cultural conditions, social needs, and the level of acceptance and cooperation of the people of each region were also recommended.


To achieve resilience in the medication supply chain during disasters, health policymakers must seek applied and context-based strategies for decreasing the waste of resources. These strategies should include sociocultural interventions, preparing necessary information infrastructures, and improving coordination among the stewards and the community during disasters. Improving logistic operations and monitoring the coordination between the local need assessments and the pharmaceutical supplies and procurement are also essential steps in improving medication supply chain resilience. 

Reference url

Recent Posts

lenacapavir HIV PrEP access
    

Global Health Partnerships Unite to Expand Access to Lenacapavir for HIV Prevention

💉 How can we ensure equitable access to HIV prevention methods like lenacapavir?

A recent initiative from the Global Fund, supported by key global health organizations, aims to provide affordable access to this new HIV pre-exposure prophylaxis medication.

With a goal to reach 2 million individuals over three years, this coordinated effort seeks to drastically cut HIV infections and align with our commitment to ending AIDS by 2030.

Explore the details of this impactful collaboration and how it could transform HIV prevention.

#SyenzaNews #globalhealth #HealthcareInnovation #MarketAccess

antimicrobial resistance africa
     

Africa’s Health Crisis: Antimicrobial Resistance and Mpox Outbreak

🌍 Are we prepared to tackle the hidden pandemic of antimicrobial resistance (AMR) in Africa?

With AMR rapidly becoming a dominant health crisis, it’s critical to understand its impact on our healthcare systems and most vulnerable populations.

The Africa CDC highlights the urgent need for substantial investment and coordinated responses to combat this escalating threat, alongside the ongoing Mpox outbreak.

Discover the pressing challenges and potential solutions in our latest article.

#SyenzaNews #GlobalHealth #HealthcareInnovation #AntimicrobialResistance #PublicHealth

BioSapien cancer drug delivery
    

BioSapien Innovative Cancer Drug Delivery Solutions

🌟 How is innovation in drug delivery shaping the future of cancer treatment? 🌟

Discover how UAE-based BioSapien is transforming the healthcare landscape with the MediChip™ platform, securing $5.5 million in pre-Series A funding to enhance cancer care.

This innovative solution promises to minimise side effects and improve treatment outcomes for patients, fully embracing the potential of biotechnology in the fight against cancer.

Read more about BioSapien’s journey and its impact on global health!

#SyenzaNews #biotechnology #oncology #innovation #HealthTech

When you partner with Syenza, it’s like a Nuclear Fusion.

Our expertise are combined with yours, and we contribute clinical expertise and advanced degrees in health policy, health economics, systems analysis, public finance, business, and project management. You’ll also feel our high-impact global and local perspectives with cultural intelligence.

SPEAK WITH US

CORRESPONDENCE ADDRESS

1950 W. Corporate Way, Suite 95478
Anaheim, CA 92801, USA

© 2024 Syenza™. All rights reserved.